Research programme: progesterone receptor modulators - Schering
Latest Information Update: 10 Jul 2006
At a glance
- Originator Bayer Schering Pharma
- Class
- Mechanism of Action Progesterone receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pregnancy
Most Recent Events
- 10 Jul 2006 No development reported - Preclinical for Pregnancy (Prevention) in Germany (PO)
- 11 Nov 2003 Preclinical trials in Pregnancy (Prevention) in Germany (PO)